AI is battling cancer, but not how you think

In oncology, progress in early detection and novel therapies has been remarkable. Yet for many patients, life after treatment remains defined by a frustrating reality: the “watch and wait” approach. Survivorship, the crucial phase after initial treatment is often overlooked, leaving patients without proactive options to reduce recurrence or improve long-term outcomes.

In a recent article, Prof. Shivan Sivakumar, Associate Professor in Oncology at the University of Birmingham, argues that the future of cancer care must address this gap. He highlights how artificial intelligence can accelerate drug repurposing by identifying safe, existing treatments that can target a wider spectrum of cancer driver mutations. This approach has the potential to give survivors real agency, moving beyond passive monitoring to personalised, proactive care.

At Astron Health, this vision deeply resonates with our mission: ensuring that cancer survivors have more than hope by providing tangible, evidence-based options to thrive.